Lupin Limited logo

Lupin Limited

NSE:LUPIN.NS

Overview | Financials
Company Name Lupin Limited
Symbol LUPIN.NS
Currency INR
Price 2,104.6
Market Cap 960,107,997,000
Dividend Yield 0.24%
52-week-range 1,153.55 - 2,312
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Ms. Vinita D. Gupta
Website https://www.lupin.com

An error occurred while fetching data.

About Lupin Limited

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health,

Related Stocks

GlaxoSmithKline Pharmaceuticals Limited logo

GlaxoSmithKline Pharmaceuticals Limited

GLAXO.NS

2,561.15 INR

Ipca Laboratories Limited logo

Ipca Laboratories Limited

IPCALAB.NS

1,558.65 INR

Laurus Labs Limited logo

Laurus Labs Limited

LAURUSLABS.NS

499.35 INR

Aurobindo Pharma Limited logo

Aurobindo Pharma Limited

AUROPHARMA.NS

1,327.55 INR

Syngene International Limited logo

Syngene International Limited

SYNGENE.NS

898.45 INR

Pfizer Limited logo

Pfizer Limited

PFIZER.NS

5,286.85 INR

Max Healthcare Institute Limited logo

Max Healthcare Institute Limited

MAXHEALTH.NS

1,079.25 INR

Fortis Healthcare Limited logo

Fortis Healthcare Limited

FORTIS.NS

620.75 INR

Alkem Laboratories Limited logo

Alkem Laboratories Limited

ALKEM.NS

5,706.5 INR

Zydus Lifesciences Limited logo

Zydus Lifesciences Limited

ZYDUSLIFE.NS

970.35 INR

Financials

Numbers are in millions USD

Numbers are in millions USD